Delveinsight

SEPTEMBER 8, 2021

The exact cause of SLE is unknown; however, factors such as sunlight and drugs may precipitate the condition, and many studies have revealed a complex genetic basis. Hydroxychloroquine and BENLYSTA are the FDA-approved therapies for SLE treatment. The severity of lupus flares ranges from moderate to severe.

Marketing 52

Marketing Sales FDA Approval Antibody 52

XTalks

AUGUST 30, 2022

A major obstacle for CNS drug developers is the inability to target therapies to the CNS broadly (for instance, a therapy that is orally bioavailable as a pill and has difficulty crossing the blood-brain barrier) and certain CNS regions more specifically. What About Small Proteins and Antibodies Reaching Extracellular CNS Targets?

Trials 83

Trials Drug Delivery Drugs Gene 83

Drug Discovery World

APRIL 17, 2023

“There are a lot of tools that we know have reduced cancer death rates substantially for specific cancers, and if those are used more broadly, with greater access, we feel that this ambitious goal might be achievable,” said Dr Meredith Shiels of NCI’s Division of Cancer Epidemiology and Genetics, who led the study.

Research 52

Research Antibody Bioavailability Genetics 52